News
Eli Lilly will seek regulatory approval for its next-generation weight-loss pill by year-end, based on data that suggests it ...
In the U.S. where adoption is highest, fewer than 1 in 10 adults are on a GLP-1 drug, despite nearly three-quarters being overweight or obese. Globally access is even more limited, held back by high ...
Weight loss drugs could be a gamechanger for women with a common hormonal disorder By Annika Kim Constantino, CNBC • Published July 20, 2025 • Updated on July 21, 2025 at 1:33 pm ...
Weight loss drugs like Ozempic can raise low testosterone — what that means for men By Tracy Swartz Published July 14, 2025, 3:00 p.m. ET ...
Second-quarter sales of the blockbuster drug soared 67% on year, despite millions of U.S. patients using generic unbranded ...
Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results